Each person admitted to the program receives a medical evaluation by a physician, or a qualified medical practitioner under the supervision of the medical director, within 14 days of admission that includes, but is not limited to, the following baseline information:
medical history, including history of narcotic dependence;
evidence of current physical dependence;
laboratory examinations, including a serological test for syphilis, a tuberculin skin test, and a toxicology test to analyze drug dependence;
determination of the presence of infectious diseases or organ abnormalities;
determination of vital signs, general appearance, and condition; and
family, economic, occupational, and housing needs.
Persons served are screened for:
high-risk behaviors related to HIV/AIDS, sexually transmitted diseases, multi drug-resistant tuberculosis, and other infectious diseases;
patterns of other drug use, including Benzodiazepines;
presence of co-occurring health and mental health conditions; and
issues related to criminal activities.
Individuals known to use Benzodiazepines, even when prescribed, should be counseled as to their risk and provided with overdose prevention education and medication to counter the effects in the event of opioid overdose.
Individuals identified as having mental health needs should receive integrated treatment directly or through referral to a cooperating service provider.